Owens & Minor, Inc. (NYSE-OMI) today updated its financial outlook for
2012, following its second quarter 2012 financial results conference
call, conducted on July 24, 2012, by company management.
“As we contemplated our outlook for the remainder of 2012, we recognize
that certain factors have come into play since we first issued our
guidance for 2012 in December of 2011,” said James L. Bierman, chief
operating officer of Owens & Minor. “These factors point to a slightly
slower growth and profitability year than we had originally planned, and
we now believe that our revenue growth for the full year of 2012 will be
below the original annual revenue guidance of 3% to 5% for our
U.S.-based operations,” said Bierman.
“Adding further complexity to our outlook for the remainder of 2012 is
our pending acquisition of the Movianto Group from Celesio AG. Our 2012
revenues will be positively impacted by the acquisition; the actual
amount will be dependent on the date of the actual closing of the
transaction in 2012,” said Bierman. Movianto’s 2011 revenues were in
excess of €300 million.
“Dilution of earnings per share related to the transaction is targeted
to be between $0.10 and $0.15 per share, much of it transaction-related
costs. As for our revised guidance for net income per diluted share for
the year, we are targeting a range of $2.04 to $1.98, excluding the
dilution associated with the pending Movianto transaction.”
Information on www.Owens-Minor.com
Owens & Minor uses its website, www.owens-minor.com,
as a channel of distribution for material company information, including
news releases, investor presentations and financial information. This
information is routinely posted and accessible under the Investor
Safe Harbor Statement
Except for historical information, the matters discussed in this press
release may constitute forward-looking statements that involve risks and
uncertainties that could cause actual results to differ materially from
those projected. These risk factors are discussed in reports filed by
the company with the Securities & Exchange Commission. All of this
information is available at www.owens-minor.com.
The company assumes no obligation, and expressly disclaims any such
obligation, to update or alter information, whether as a result of new
information, future events, or otherwise.
Owens & Minor, Inc., (NYSE: OMI)
a FORTUNE 500 company headquartered in Richmond, Virginia, is a
leading national distributor of name-brand medical and surgical supplies
and a healthcare supply-chain management company. Owens & Minor is also
a member of the Russell 2000® Index, which measures the
performance of the small-cap segment of the U.S. equity universe, as
well as the S&P MidCap 400, which includes companies with a market
capitalization of $1 billion to $4.4 billion that meet certain financial
standards. With a diverse product and service offering and distribution
centers throughout the United States, the company serves hospitals,
integrated healthcare systems, alternate site locations, group
purchasing organizations, healthcare suppliers, and the federal
government. Owens & Minor provides technology and consulting programs
that improve inventory management and streamline logistics across the
entire medical supply chain – from origin of product to patient bedside.
For news releases, or for more information about Owens & Minor, visit
the company website at www.owens-minor.com.